HH
Insider
Heidi Henson
DirectorHeidi Henson (Director) filed 1 Form 4 report in the past 24 months (1 purchase, 0 sales), most often in Perspective Therapeutics, Inc. (CATX). Across 1 priced purchase filing, the average 21-session return was -12.5% from execution and -0.5% from disclosure (delay-adjusted; derived). The largest single filing was $100K of CATX (25,975 sh × $3.85, as filed), executed Dec 4 2024.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
-12.5%
avg across 1 priced filings
Delay-adjustediThe same average, entered at disclosure dates
-0.5%
same 1 filings, from disclosure
Filings, ttm
1
1 buys · 0 sells
Median delay
2d
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$100K
shares × price, as filed
Last traded
Dec 4 2024
Filed Dec 6 2024
Median ADV $5.1M across their filed names
Open performance→Volume by month
Buys $100K
Sells $0
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 24 months
Most traded names
CATXRecent filings
CATXPURCHASE
Perspective Therapeutics, Inc.
View filing →
$100K25,975 sh × $3.85
Exec Dec 4 2024
Filed Dec 6 2024 · 5:30 PM ET